Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

• Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

  The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
  
  CNBC - 3d

• Hims & Hers offers upbeat forecast, but stock slides after hours

  Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading, in an echo ...
  
  MarketWatch - 15h

• Nicolas Cage's ex is suing him and their son. She says Weston Cage beat her and dad shares blame

  Nicolas Cage's attorney dismisses the allegations made by Christina Fulton, who's suing Weston Cage for assault and Nicolas for failing to prevent their son from committing acts of violence.
  
  Los Angeles Times - 5d

• Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

  Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
  
  CNBC - 3d

• Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

  Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.
  
  CNBC - 16h

• Hims & Hers shares plunge 28% on concerns over weight loss business, margins

  Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
  
  CNBC - 37m
• 

  Ukrainians rally around their president after Trump seeks to denigrate him

  Days before the third anniversary of Russia’s full-scale invasion, Ukrainians are as somber and tense as they were right before Moscow launched the war
  
  ABC News - 4d

• FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

  “We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
  
  MarketWatch - 3d

• Trump’s Rift With Europe Adds Fuel to a Rally in Defense Stocks

  A flurry of trading has helped push the Pan-European Stoxx 600 index to a record high as investors expect Europe’s governments to increase military spending.
  
  The New York Times - 6d

More from MarketWatch

• No ‘golden age’ is coming. Trump’s tariffs will hit Americans with higher interest rates and more inflation.

  Protectionism won’t make us rich — especially if tariffs launch a trade war.
  
  MarketWatch - 16m

• Consumer confidence sinks to 8-month low on worries about inflation and Trump tariffs

  A postelection high in consumer confidence after the election of Donald Trump has petered out, as the public digests major upheavals in U.S. economic policies by the new White House.
  
  MarketWatch - 17m

• Trump’s tariffs unleashed a wave of uncertainty among investors. Why that’s a good thing.

  Processing our uncertainty — or rather, being comfortable with it — can help us sharpen our problem-solving capabilities.
  
  MarketWatch - 43m

• U.S. oil prices touch lowest levels of the year as tariff threat hurts demand outlook

  Oil futures declined Tuesday, with U.S. benchmark prices falling under $70 a barrel to touch their lowest levels of the year, with the economy and energy demand expected to take a hit from proposed ...
  
  MarketWatch - 53m

• This trend has important implications for Social Security’s full retirement age

  New data show strong relationship between earnings and life expectancy
  
  MarketWatch - 54m

More in Business

• 

  US stocks slide as consumer confidence sinks most in four years

  Americans’ inflation expectations surge as rising prices for staples and tariff worries hit sentiment, key survey shows
  
  Financial Times - 16m

• No ‘golden age’ is coming. Trump’s tariffs will hit Americans with higher interest rates and more inflation.

  Protectionism won’t make us rich — especially if tariffs launch a trade war.
  
  MarketWatch - 16m

• Amid risks to Education Dept., borrowers should 'immediately' take key actions, consumer advocates say

  Amid the threats to the Education Dept. and reports that Musk's DOGE had gained access to student loan borrower data, consumer advocates are issuing warnings.
  
  CNBC - 17m

• How digitally native companies like Rothy's are growing profitably in a new era for retail

  Flats maker Rothy's is growing profitably after expanding into wholesale and building its store fleet. In 2024, it saw sales grow 17%.
  
  CNBC - 17m

• Consumer confidence sinks to 8-month low on worries about inflation and Trump tariffs

  A postelection high in consumer confidence after the election of Donald Trump has petered out, as the public digests major upheavals in U.S. economic policies by the new White House.
  
  MarketWatch - 17m